Ozempic-maker sues rival, accusing it of false advertising
Novo Nordisk, the maker of Wegovy and Ozempic, has launched legal action accusing its arch rival Eli Lilly of false advertising.
· 7/21/2026, 1:47:23 PM· 2 min read
Novo Nordisk, the maker of Wegovy and Ozempic, has launched legal action accusing its arch rival Eli Lilly of false advertising.
Read original story →Related stories
business
Indian Oil Corporation cancels Iraq oil lifting amid attacks, sources say
business
Bajaj Auto Q1 net profit surges 46% to ₹3,226 crore aided by volume and exports growth
business
Maruti Suzuki to increase prices from August as input costs rise
business